Compare Kenvue Inc. Common Stock (KVUE) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs 22nd Century Group Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Kenvue Inc. Common Stock is far larger — about 54787.9× 22nd Century Group Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| KVUE | XXII | |
|---|---|---|
Market Cap | $34.06B | $621.67K |
Volume | 23,267,228 | 45,625 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $19.83 | $483.00 |
52-Week Low | $14.11 | $0.80 |
Enterprise Value | $41.56B | -$3.69M |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 32 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
